Pearl River Capital’s Surmodics SRDX Stock Holding History

Pearl River Capital’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-958	Closed	-$42K	–	453
2019 Q1	$42K	Buy	958 +601	+168%	+$30.6K	0.1%	254
2018 Q4	$17K	Buy	+357	New	+$21.4K	0.08%	359

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pearl River Capital's SRDX Position: Q2 2019 in Review

Pearl River Capital sold out of Surmodics (SRDX) in Q2 2019, closing a stake of 958 shares — an estimated $42K sold.

Pearl River Capital first reported a position in SRDX in Q4 2018 and held it in 2 quarters. The position peaked at $42K in Q1 2019. 140 funds tracked by Wall St. Rank hold SRDX as of Q2 2019.

Pearl River Capital reported no remaining Surmodics position as of Q2 2019 after selling out during the quarter.
Pearl River Capital sold 958 Surmodics shares in Q2 2019, an estimated $42K.
Pearl River Capital first reported a position in Surmodics in Q4 2018 and held it in 2 quarters.
Pearl River Capital's Surmodics position peaked at $42K in Q1 2019.
140 funds tracked by Wall St. Rank held Surmodics as of Q2 2019.

Based on Pearl River Capital's 13F filing for Q2 2019, filed 12 Aug 2019.